Molecular Infectious Disease Testing Market worth $19.09 billion by 2031 | MarketsandMarkets™
According to the company, the Molecular Infectious Disease Testing Market is projected to grow from approximately USD 11.30 billion in 2026 to USD 19.09 billion by 2031, representing a compound annual growth rate (CAGR) of 11.1%.
The market analysis indicates that North America held the largest market share in 2025. The reagents and kits segment is expected to register the highest growth rate of 11.9% during the forecast period. In 2025, the singleplex testing segment accounted for the largest market share, while laboratory tests are anticipated to generate the highest CAGR during the forecast period. Additionally, sexually transmitted diseases represented 41.0% of the market share by disease category in 2025, with the polymerase chain reaction segment holding a 44.1% market share by technology.
The molecular infectious disease testing market is categorized by product and service into three segments: reagents and kits, instruments, and services and software. The reagents and kits segment is expected to grow rapidly, driven by the increasing demand for efficient diagnostic tools in clinical settings. This segment is pivotal for PCR testing, next-generation sequencing, and other molecular assays.
The market also differentiates between singleplex and multiplex testing, with multiplex testing anticipated to lead in growth due to its ability to simultaneously detect multiple pathogens. This method is becoming increasingly valuable in diagnosing complex infections. Moreover, the rise in patient numbers at healthcare facilities is contributing to the higher demand for multiplex tests.
The main end users of molecular infectious disease testing include diagnostic laboratories and hospitals, with diagnostic laboratories demonstrating a primary role due to the increasing need for rapid and accurate testing methods. The continued advancements in technology such as PCR and multiplexing are expected to drive market growth and improve disease management and prevention strategies.